AXNX News and Press, Axonics Modulation Technologies Inc. From 11/17/19

Image source: The Motley Fool. Axonics Modulation Technlogs INC   (NASDAQ: AXNX) Q3 2019 Earnings Call Nov 14, 2019 , 4:30 p.m. ET Operator Continue reading

Axonics Modulation Technologies, Inc. (AXNX) Q3 2019 Earnings Conference Call November 14, 2019 04:30 PM ET Company Participants Matt Clawson - Investor Relations, Practice Leader and Investor Relations at W2O Group Raymond Cohen - Chief Executive Officer Dan Dearen - President &...

Axonics Modulation Technologies (NASDAQ: AXNX ): Q3 GAAP EPS of -$0.89 misses by $0.15 . Revenue of $1.31M (+555.0% Y/Y) misses by $0.14M . Press Release More news on: Axonics Modulation Technologies, Inc., Earnings news and commentary, Healthcare stocks news,

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, reported today financial results for the thir...

Gainers:  Astrotech Corporation (NASDAQ: ASTC ) +87% . More news on: Astrotech Corporation, Pier 1 Imports, Inc., Celsion Corporation, Stocks on the move, Read more ...

Shares of Axonics Modulation Technologies (NASDAQ: AXNX) , a medical device company focused on bladder and bowel dysfunction , rose 15% as of 11:00 a.m. EST on Thursday. The double-digit jump is a response to the news that the company won FDA approval for its Axonics r-SNM (rechargeable sacr...

Exicure (NASDAQ: XCUR ) +30%  on collaboration with Allergan in hair loss disorders. More news on: Exicure, Inc., Opera Limited, Ping Identity Holding Corp., Stocks on the move, Read more ...

The FDA approves Axonics Modulation Technologies' (NASDAQ: AXNX ) Axonics r-SNM System for clinical indications of overactive bladder and urinary retention. More news on: Axonics Modulation Technologies, Inc., Healthcare stocks news, Read more ...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced the approval of ...

The following healthcare companies have filed for mixed shelf offerings: More news on: Cytokinetics, Incorporated, Twist Bioscience Corporation, Axonics Modulation Technologies, Inc., Healthcare stocks news, Read more ...